Acetaminophen 325 mg pharmacology

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Acetaminophen 325 mg: Pharmacology Overview

Acetaminophen 325 mg Formulations and Use

Acetaminophen, also known as paracetamol, is widely available in 325 mg tablets, both as a single agent and in combination with other medications such as tramadol or oxycodone for pain relief and fever reduction Mazaleuskaya201556. The 325 mg dose is common in over-the-counter products and is often used in fixed-dose combinations to optimize pain management while minimizing the risk of toxicity Kim2022Franke20156.

Mechanism of Action and Therapeutic Effects

Acetaminophen acts as an analgesic and antipyretic, providing relief from mild to moderate pain and reducing fever. It is indicated for use in both adults and children, with typical adult therapeutic doses ranging from 1 to 2 grams per day, not exceeding a maximum of 4 grams per day to avoid toxicity .

Pharmacokinetics of Acetaminophen 325 mg

After oral administration, acetaminophen is rapidly absorbed, with both immediate-release and extended-release formulations available. Extended-release tablets may contain 325 mg of immediate-release acetaminophen combined with an additional 325 mg of delayed-release acetaminophen, resulting in variable absorption rates and potentially delayed peak plasma concentrations Michienzi20215. Studies show that the pharmacokinetic profiles of 325 mg acetaminophen in combination products are consistent and bioequivalent to higher-dose formulations when taken as directed Kim2022Franke2015.

Metabolism and Safety Considerations

Acetaminophen is primarily metabolized in the liver. At therapeutic doses, it is safely processed, but at higher doses, a toxic metabolite (NAPQI) can accumulate, leading to liver and kidney damage . The risk of hepatotoxicity has led regulatory agencies to limit the amount of acetaminophen per tablet to 325 mg and to require clear warnings about potential liver damage . Overdose, even with 325 mg tablets, can occur if multiple products containing acetaminophen are taken simultaneously or if dosing guidelines are exceeded, especially in children Mazaleuskaya20156.

Special Considerations for Extended-Release Formulations

Extended-release acetaminophen tablets in the US typically contain 325 mg of immediate-release and 325 mg of delayed-release acetaminophen. Overdose with these formulations can result in unpredictable absorption and delayed peak concentrations, complicating clinical management and requiring careful monitoring Michienzi20215.

Conclusion

Acetaminophen 325 mg is a widely used and effective analgesic and antipyretic, available in various formulations and combinations. Its pharmacokinetics are well understood at therapeutic doses, but caution is necessary to avoid overdose and potential liver toxicity, especially with extended-release products and in pediatric populations Kim2022Franke2015Mazaleuskaya2015+3 MORE.

Sources and full results

Most relevant research papers on this topic

Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination

The extended-release tramadol 37.5 mg/acetaminophen 325 mg ER FDC (DW-0920) is comparable to the reference formulation, offering optimal pain control with a lower dose.

RCTVery Rigorous Journal

2022·

0citations

·Hyun Chul Kim et al.

Translational and Clinical Pharmacology·

DOI

Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets

The single-dose population pharmacokinetics of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets are not clinically relevant, with race and meal consumption having small pharmacokinetic effects.

Rigorous Journal

2015·

7citations

·R. Franke et al.

Drug Design, Development and Therapy·

DOI

PharmGKB summary: Pathways of acetaminophen metabolism at the therapeutic versus toxic doses

Acetaminophen is a widely used analgesic and antipyretic agent, with therapeutic doses ranging from 1 to 4 g/day and toxic doses exceeding 7 g/day in adults and 150 mg/kg/day in children.

Highly Cited

2015·

299citations

·Liudmila L. Mazaleuskaya et al.

Pharmacogenetics and genomics·

DOI

Extended Release Acetaminophen Overdose With Delayed Peak Concentrations

Extended-release acetaminophen overdose treatment requires a different approach than short-acting acetaminophen overdose treatment, as it has unpredictable pharmacokinetics and variable absorption rates.

Case Report

2021·

1citation

·A. Michienzi et al.

American Journal of Therapeutics·

DOI

Metabolism of Acetaminophen 3

Acetaminophen is an over-the-counter medication that is commonly ingested as 325 or 500 mg tablets, and is the major metabolite of phenacetin.

2007·

0citations

PRODUCTS CONTAINING ACETAMINOPHEN ALONE OR IN COMBINATION

A large number of products containing acetaminophen are on the market in the United States, enhancing the probability of accidental ingestion of toxic quantities by infants and children.

1973·

0citations

Pediatrics·

DOI

OTC Quick Reference - Dental

A combination of ibuprofen and acetaminophen is more effective than opioids for dental pain control and carries less risk for adverse events.

2022·

0citations

DOI

Fatal case of acute necrotic pancreatitis secondary to chronic abuse of acetaminophen: a case report

Chronic abuse of acetaminophen can lead to fatal acute necrotic pancreatitis, emphasizing the need for periodic monitoring of patients taking acetaminophen within the recommended daily dose.

Case Report

2023·

0citations

·Amarthya S. Racha et al.

International Journal of Basic & Clinical Pharmacology·

DOI

Declining rates of opioid/acetaminophen combination product overdose: 2011–2020

The FDA's 2014 rule limiting acetaminophen in combination products to 325 mg reduced unintentional acetaminophen supratherapeutic ingestions, potentially reducing hepatotoxicity risks in opioid-related emergency department cases.

Observational Study

2023·

1citation

·E. Harris et al.

Hepatology Communications·

DOI

FDA acts to limit exposure to acetaminophen in combination products

Stop prescribing combination drug products with more than 325 mg of acetaminophen per dosage unit, as this may increase the risk of liver injury.

Very Rigorous Journal

2014·

10citations

·M. McCarthy

BMJ : British Medical Journal·

DOI

Try another search

alcohol interaction with lisinopril

inhaler technique effectiveness

monkeys in space program

praluent efficacy and safety

white blood cells function

ways to reduce carbon footprint